- Breaking News Camera club winners
- Breaking News San Mateo County ninth-graders struggle to stay fit
- Breaking News Food and wine events
- Breaking News Ask Amy: What To Do When the Doctor Isn t in the House
Later-stage venture capital investment in europerises to highest point in three years, fueled by improved IPO market; Ernst & Young/ Dow Jones VentureOne quarterly European venture capital report finds annual median deal size grows to *2 million--highest median since 2000.
0 Comments | M2 Presswire, February, 2006
M2 PRESSWIRE-13 February 2006-DOW JONES: Later-stage venture capital investment in europerises to highest point in three years, fueled by improved IPO market; Ernst & Young/ Dow Jones VentureOne quarterly European venture capital report finds annual median deal size grows to *2 million--highest median since 2000(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:13022006 LONDON and NEW YORK - Driven by an improved liquidity market in Europe, later-stage venture capital investments grew to *1.76 billion in 2005, the most invested to this round class since 2002.
But overall venture capital investing into European companies slowed compared to 2004. In total, 1,020 financing rounds were completed and *3.60 billion was invested, which translates to a decline of 16 and 5,...
- Getting to the root of beautiful hair: shiny, silky hair begins with a healthy scalp - includes list of resources and a recipe for an herbal scalp tonic
- Industry Experts Launch Money Management Resources to Help People Overcome Debt and Learn Proper Money Management Practices
- Portfolio forecasting tools: what you need to know
- Made from scratch: When Honda built a plant in Alabama it also built a workforce-using local workers who had no experience in making cars - Recruitment & Hiring
- Banking technology, technological learning and competition: comparative case studies in Thai banking
- John Seely Brown Inducted Into 2004 Industry Hall of Fame
- SmartDisk's New VST Flash Media Reader(TM) Reads SmartMedia(TM), CompactFlash(TM) From A Single Desktop Unit
- FDA Approves REMICADE(R) for Ninth Indication: Psoriatic Arthritis